Preexisting Thyroid Disease in Pregnancy: A Brief Overview.
Document Type
Article
Publication Date
7-2022
Identifier
PMCID: PMC9462902
Abstract
Maternal thyroid disease, with both an excess or deficiency of thyroid hormone, raises the risk profile of affected pregnancies with regards to preeclampsia, preterm birth, placental problems, thyroid derangement of the fetus and neonate, and neurodevelopment of exposed fetuses later in life. Fortunately, close and tight management of thyroid disease within the fluctuating physiologic milieu of pregnancy offers opportunities to significantly improve perinatal outcomes. However, despite guidelines offered by American College of Obstetrics and Gynecology (ACOG) and American Thyroid Association (ATA), controversy persists regarding interpretation of thyroid labs, screening for disease, surveillance, fetal and placental thyroid physiology, and optimal medication and management strategies. This is a brief overview of what is known and unknown regarding thyroid disease and its impact on maternal, fetal, and pregnancy health.
Journal Title
Missouri medicine
Volume
119
Issue
4
First Page
360
Last Page
365
MeSH Keywords
Female; Humans; Infant, Newborn; Placenta; Pregnancy; Pregnancy Complications; Premature Birth; Thyroid Diseases; Thyroid Hormones; United States
Keywords
Placenta; Pregnancy; Pregnancy Complications; Premature Birth; Thyroid Diseases; Thyroid Hormones; United States
Recommended Citation
Maulik D, Chuy V, Kumar S. Preexisting Thyroid Disease in Pregnancy: A Brief Overview. Mo Med. 2022;119(4):360-365.
COinS
